logo
Sign in

BMKDF Stock Price, Chart, Stats & News

BioMark Diagnostics Inc.
Save

BioMark Diagnostics Inc. (BMKDF) does not currently pay a dividend.

45.17M
Market cap
Current P/E
Forward P/E

BMKDF chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Medical - Diagnostics & Research
Industry

BioMark Diagnostics Inc. is an oncology-focused firm that develops sophisticated diagnostic tools for cancer. These solutions are designed to aid in the identification of the disease, its ongoing monitoring, and the assessment of initial therapeutic interventions. The company has a research partnership with the Icahn School of Medicine, under which they conduct clinical studies concentrating on the early detection of lung cancer.

Similar securities

Based on sector and market capitalization

Report issue